Cargando…
Prognostic Factors for Hormone Sensitive Metastatic Prostate Cancer: Impact of Disease Volume
BACKGROUND AND AIM: The optimal management of metastatic hormone-sensitive prostate cancer has been controversial in recent years with introduction of upfront chemohormonal treatment based on results of several Western studies. This changing landscape has renewed interest in the concept “disease vol...
Autores principales: | Alhanafy, Alshimaa Mahmoud, Zanaty, Fouad, Ibrahem, Reda, Omar, Suzan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031775/ https://www.ncbi.nlm.nih.gov/pubmed/29699372 http://dx.doi.org/10.22034/APJCP.2018.19.4.1113 |
Ejemplares similares
-
Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer
por: Soliman, Shimaa El-Shafey, et al.
Publicado: (2018) -
The Role of Diuretics in Treatment of Aromatase Inhibitors Induced Musculoskeletal Symptoms in Women with Non Metastatic Breast Cancer
por: Alhanafy, Alshimaa Mahmoud, et al.
Publicado: (2018) -
Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer
por: Lee, Ji Hyun, et al.
Publicado: (2021) -
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy
por: Verzoni, Elena, et al.
Publicado: (2022) -
Non Size Based Morphology Criteria for Assessment of Response in Patients with Liver Metastases of Gastrointestinal Origin Receiving Systemic Treatment
por: Alhanafy, Alshimaa, et al.
Publicado: (2018)